IOMED (Drug Delivery) Overview
- Founded
-
1974

- Status
-
Acquired/Merged
- Employees
-
48

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
IOMED (Drug Delivery) General Information
Description
Manufacturer and distributor of drug delivery devices used primarily for the management of pain. The company offers iontophoresis technology primarily for transdermal drug delivery and for the treatment of ophthalmic disease. It also markets a self-contained iontophoresis system, the Companion 80 that provides a mobile solution allowing the patient to resume daily activity and the clinician to optimize the use of patient time in the clinic. It's products are used for site-specific corticosteroid therapy in clinics to treat various conditions, including those suffered by professional, collegiate, and Olympic athletes. Its products are also used by clinicians to deliver a range of other water-soluble ionic medicaments for treatment of a variety of conditions.
Contact Information
- 2441 South 3850 West
- Suite A
- Salt Lake City, UT 84120
- United States
IOMED (Drug Delivery) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
IOMED (Drug Delivery) Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Robert Lollini | President & CEO & Director | ||
Brian Mower | Chief Financial Officer & Chief Accounting Officer | ||
James Cronkrite | Director |